StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.20−0.00 (-1.49%)

Close on Nov 16, 2026Market cap $893.37KP/E –Yield –

Oragenics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Oragenics's market cap was $1.54M on Nov 11, 2026, against $3.59M a year earlier. Over the last 5 years it ranged from $847.62K to $16.15B, with a median of $139.81M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.54M-52.4%
2025Dec 31, 2025$3.23M-96.9%
2024Dec 31, 2024$104.01M-76.0%
2023Dec 29, 2023$433.73M+8.3%
2022Dec 30, 2022$400.45M-75.1%
2021Dec 31, 2021$1.61B+89.5%
2020Dec 31, 2020$849.99M+13.5%
2019Dec 31, 2019$748.58M+52.5%
2018Dec 31, 2018$490.86M+36.7%
2017Dec 29, 2017$359.18M-56.4%
2016Dec 30, 2016$823.01M-51.5%
2015Dec 31, 2015$1.70B+69.9%
2014Dec 31, 2014$999.28M-62.0%
2013Dec 31, 2013$2.63B+18.0%
2012Dec 31, 2012$2.23B+1151.3%
2011Dec 30, 2011$178.13M–

More Oragenics figures

See a number that looks wrong?